2026-03353Notice

FDA Asks: Thoughts on Paperwork for Rare Animal Meds?

Published Date: 2/20/2026

Notice

Summary

The FDA wants your thoughts on how they collect info about new animal drugs for less common animals and uses. This helps make sure these drugs are safe and effective without causing extra paperwork headaches. If you’re involved with these drugs, you’ve got until April 21, 2026, to share your comments—no cost, just your voice!

Analyzed Economic Effects

4 provisions identified: 2 benefits, 2 costs, 0 mixed.

7‑Year Exclusivity for MUMS Sponsors

If you sponsor a designated Minor Use or Minor Species (MUMS) new animal drug, the designation makes you eligible for incentives including a 7‑year period of exclusive marketing rights. The designation is optional but the FDA uses sponsor submissions to determine eligibility for these benefits.

Indexing Lets Some Unapproved Drugs Be Marketed

FDA rules let certain unapproved new animal drugs for minor species be added to an Index so they can be legally marketed for those species. The indexing program is intended to make more medications legally available to veterinarians and animal owners for treatment of minor species.

Estimated Paperwork Burden on Sponsors

FDA estimates the total annual reporting burden for this information collection is 5,562 hours and the total annual recordkeeping burden is 80 hours. FDA reports an overall increase of 60 hours and a corresponding increase of 120 responses and records compared with prior estimates.

Annual Reports, eSubmitter, and Recordkeeping Rules

Sponsors of MUMS‑designated drugs must demonstrate “due diligence” by submitting annual reports documenting progress for each designation and may use FDA's eSubmitter system (access requires a previously established account). Qualified expert panel leaders must keep written reports and related notes for 2 years, and holders of indexed drugs must maintain records of safety or effectiveness information.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
Comments Due
2/20/2026
4/21/2026

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML
Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in